PanCO: Updated Results of an Open-Label, Single-Arm Pilot Study of OncoSil P-32 Microparticles in Combination with Standard-of-Care (SoC) Gemcitabine + Nab-Paclitaxel or FOLFIRINOX Chemotherapy in Unresectable Locally Advanced Pancreatic Cancer (uLAPC)
Titel:
PanCO: Updated Results of an Open-Label, Single-Arm Pilot Study of OncoSil P-32 Microparticles in Combination with Standard-of-Care (SoC) Gemcitabine + Nab-Paclitaxel or FOLFIRINOX Chemotherapy in Unresectable Locally Advanced Pancreatic Cancer (uLAPC)
Auteur:
Ross, Paul Hendlisz, Alain Ajithkumar, Thankamma Iwuji, Chinenye Harris, Marion Croagh, Daniel Aghmesheh, Morteza Nagrial, Adnan Nguyen, Nam Nikfarjam, Mehrdad Wilson, Nicole Kenny, Daniel Turner, David Wasan, Harpreet S.